Clinical trial
ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment
NCT00331097 · National Cancer Institute, Naples, Other · Completed
Key facts
| NCT number | NCT00331097 |
|---|---|
| Title | ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment |
| Official title | Adjuvant Chemotherapy in Elderly Patients With Breast Cancer: Weekly Docetaxel vs. CMF |
| Lead sponsor | National Cancer Institute, Naples, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | docetaxel, cyclophosphamide, methotrexate, 5-fluorouracil |
| Enrollment | 300 |
| Start date | Jul 1, 2003 |
| Primary completion | May 1, 2014 |
| Completion | Nov 1, 2014 |
| First posted | May 29, 2006 |
| Last update posted | Mar 28, 2017 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: